DK541889D0 - Virus-modificerede tumorvacciner til immunterapi af tumormetastaser - Google Patents

Virus-modificerede tumorvacciner til immunterapi af tumormetastaser

Info

Publication number
DK541889D0
DK541889D0 DK541889A DK541889A DK541889D0 DK 541889 D0 DK541889 D0 DK 541889D0 DK 541889 A DK541889 A DK 541889A DK 541889 A DK541889 A DK 541889A DK 541889 D0 DK541889 D0 DK 541889D0
Authority
DK
Denmark
Prior art keywords
pct
virus
tumor
immunery
modified
Prior art date
Application number
DK541889A
Other languages
Danish (da)
English (en)
Other versions
DK541889A (da
Inventor
Volker Schirrmacher
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6348527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK541889(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of DK541889A publication Critical patent/DK541889A/da
Publication of DK541889D0 publication Critical patent/DK541889D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK541889A 1988-03-01 1989-10-31 Virus-modificerede tumorvacciner til immunterapi af tumormetastaser DK541889D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3806565A DE3806565A1 (de) 1988-03-01 1988-03-01 Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
PCT/EP1989/000186 WO1989007946A1 (fr) 1988-03-01 1989-02-27 Vaccins tumoraux modifies viralement pour immunotherapie de metastases tumorales

Publications (2)

Publication Number Publication Date
DK541889A DK541889A (da) 1989-10-31
DK541889D0 true DK541889D0 (da) 1989-10-31

Family

ID=6348527

Family Applications (1)

Application Number Title Priority Date Filing Date
DK541889A DK541889D0 (da) 1988-03-01 1989-10-31 Virus-modificerede tumorvacciner til immunterapi af tumormetastaser

Country Status (10)

Country Link
US (1) US5273745A (fr)
EP (1) EP0331102B1 (fr)
JP (1) JPH02504034A (fr)
KR (1) KR900700130A (fr)
AT (1) ATE90877T1 (fr)
AU (1) AU3188989A (fr)
DE (2) DE3806565A1 (fr)
DK (1) DK541889D0 (fr)
ES (1) ES2042828T3 (fr)
WO (1) WO1989007946A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922444A1 (de) * 1988-03-01 1991-01-10 Deutsches Krebsforsch Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen
DE4204132C2 (de) * 1991-02-12 1997-12-18 Rudolf Dr Pekar Aufbereitung für die Gewinnung von Vakzinen für eine Immuntherapie
DE69232890T2 (de) * 1991-10-04 2003-10-09 Whitehead Biomedical Inst Regulierung der systemischen immunantworten mittels zytokinen und antigenen
JP4338781B2 (ja) 1993-04-30 2009-10-07 ウェルスタット バイオロジクス コーポレイション ウイルスを用いる癌の処置および検出方法
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
EP0805207A1 (fr) * 1996-05-02 1997-11-05 Gesellschaft für Biotechnologische Forschung mbH (GBF) Plasmide d'expression polycistronique pour la réjection de tumeurs
ATE245163T1 (de) * 1996-05-03 2003-08-15 Univ Jefferson Impfstoff gegen metastasierenden kolorektalkrebs.
NZ330995A (en) * 1996-10-04 2000-12-22 Univ Jefferson Generation of T cells mediating an immune response and use for treating cancer
DE69731950T2 (de) * 1997-08-22 2005-05-19 Science Park Raf S.P.A. Tumorvakzinierung mittels Verwendung autologer oder HLA-verwandter Antigen präsentierender Zellen (APC), die mit einem Tumorantigen sowie einem eine Immunantwort hervorrufenden Fremdantigen transduziert sind
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US7780962B2 (en) * 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
US20030044384A1 (en) * 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
HUP0302278A3 (en) * 1999-04-15 2011-01-28 Pro Virus Treatment of neoplasms with viruses
US8147822B1 (en) * 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
EP1092439A1 (fr) * 1999-10-13 2001-04-18 Thorsten Dr. Ahlert Activation de cellules T antigène spécifiques par des cellules dendritiques traitées par un virus/antigène
RU2172182C1 (ru) * 2000-07-27 2001-08-20 Бритов Василий Александрович Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
WO2004096244A1 (fr) * 2003-05-02 2004-11-11 Md Bioalpha Co. Ltd. Procede de preparation d'un vaccin pour induire une activite antitumorale et composition pharmaceutique le comprenant
AP2911A (en) 2005-12-02 2014-05-31 Sinai School Medicine Chimeric Viruses presenting non-native surface proteins and uses thereof
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
WO2010030002A1 (fr) 2008-09-12 2010-03-18 国立大学法人三重大学 Cellule capable d'exprimer un ligand gitr exogène
WO2010036652A1 (fr) * 2008-09-23 2010-04-01 Thomas Jefferson University Vaccins anticancéreux contre des antigènes de muqueuse et procédés de préparation et d’utilisation de ceux-ci
DK2327764T3 (da) 2009-11-30 2012-04-02 United Cancer Res Inst Ny klon af Newcastle disease-virus, dens fremstilling og dens anvendelse ved medicinsk behandling af cancer
PE20151921A1 (es) 2013-03-14 2015-12-26 Icahn School Med Mount Sinai Virus de la enfermedad de newcastle y usos de los mismos
CN107073099B (zh) 2014-02-27 2022-09-27 默沙东公司 用于治疗癌症的联合方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
DE3432714A1 (de) * 1984-09-06 1986-04-24 Behringwerke Ag, 3550 Marburg Tumortherapeutikum und verfahren zu seiner herstellung
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection

Also Published As

Publication number Publication date
KR900700130A (ko) 1990-08-11
DE3806565A1 (de) 1989-09-14
DE58904760D1 (de) 1993-07-29
DK541889A (da) 1989-10-31
US5273745A (en) 1993-12-28
EP0331102B1 (fr) 1993-06-23
DE3806565C2 (fr) 1991-04-25
ATE90877T1 (de) 1993-07-15
WO1989007946A1 (fr) 1989-09-08
JPH02504034A (ja) 1990-11-22
AU3188989A (en) 1989-09-22
ES2042828T3 (es) 1993-12-16
EP0331102A1 (fr) 1989-09-06

Similar Documents

Publication Publication Date Title
DK541889A (da) Virus-modificerede tumorvacciner til immunterapi af tumormetastaser
DE69030172T2 (de) Impfstoffe gegen Krebs und Infektionskrankheiten
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
ATE391726T1 (de) Modifiziertes gp100 und dessen verwendung
ATE402713T1 (de) Genetisch manipulierte herpesviren zur behandlung von tumoren
DE3689622D1 (de) Impfstoffe gegen menschliche respiratorische viren.
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
DK0889969T3 (da) Rekombinante adenovirale til genterapi af humane tumorer
ES553425A0 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
NO923659D0 (no) Gp75 som en tumorvaksine for melanom
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
BR9306187A (pt) Vacina bacterin-toxóide pasteurella haemolytica tipo a-1
AR015237A1 (es) Una composicion de membranas celulares tumorales modificadas con hapteno, metodo para obtenerlas y su uso.
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
KR890006254A (ko) 비-특이적 면역성 인듀서의 제조방법
SE9202934D0 (sv) Vacciner mot melanom
NL300073I1 (nl) Vaccin.
DE216901T1 (de) Immunogenes antigen-traeger-proteinkonjugat zur verwendung in impfstoffen gegen malaria.
IL85266A0 (en) Newcastle disease virus(ndv)vaccine and method for the application thereof

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment